Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Other Operating Expenses (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Other Operating Expenses for 5 consecutive years, with $6.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses rose 4.24% year-over-year to $6.1 million, compared with a TTM value of $23.7 million through Sep 2025, down 2.54%, and an annual FY2024 reading of $24.2 million, down 0.63% over the prior year.
  • Other Operating Expenses was $6.1 million for Q3 2025 at Lucid Diagnostics, up from $5.7 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $14.2 million in Q4 2021 and bottomed at -$12.5 million in Q1 2022.
  • Average Other Operating Expenses over 5 years is $4.7 million, with a median of $5.9 million recorded in 2024.
  • The sharpest move saw Other Operating Expenses crashed 241.06% in 2022, then soared 147.92% in 2023.
  • Year by year, Other Operating Expenses stood at $14.2 million in 2021, then tumbled by 47.98% to $7.4 million in 2022, then fell by 13.67% to $6.4 million in 2023, then dropped by 1.81% to $6.3 million in 2024, then dropped by 2.59% to $6.1 million in 2025.
  • Business Quant data shows Other Operating Expenses for LUCD at $6.1 million in Q3 2025, $5.7 million in Q2 2025, and $5.7 million in Q1 2025.